Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women
Condition(s) studied
Investigational drug(s) / intervention(s)
Morning exercise group: Participants perform supervised exercise sessions at 07:00h
Evening exercise group: Participants perform supervised exercise sessions at 19:00h
Usual-care control group: Participants receive lifestyle recommendations without exercise
Study summary
Type of Study: Clinical Trial
Goal: The goal of this clinical trial is to investigate how performing exercise at different times of day (morning vs. evening) affects liver fat, cardiometabolic health, and gut microbiota in postmenopausal women.
Participant Population/Health Conditions: The study will involve 63 sedentary postmenopausal women (aged 45-75) diagnosed with metabolic dysfunction-associated steatotic liver disease.
Main Questions: The main questions this study aims to answer are:
* Does morning exercise reduce hepatic fat more effectively than evening exercise?
* How does time-of-day-specific exercise influence cardiometabolic markers?
* Do changes in gut microbiota contribute to the metabolic effects of exercise timing?
Participants Will:
Be randomized into one of three groups: morning exercise, evening exercise, or a usual-care control group.
Follow the assigned regimen for 12 weeks. The exercise groups will perform supervised aerobic and resistance training three times per week.
Provide blood, stool, and imaging data before and after the intervention to determine the effects of the intervention.
Comparison Group:
Researchers will compare the effects of morning vs. evening exercise (and usual care) on hepatic fat reduction and cardiometabolic improvement, as well as changes in gut microbiota.
Eligibility
Primary outcome measure(s)
- Hepatic fat content — Change from baseline in the mean adipose tissue content at 12 weeks
Hepatic fat content will be quantified using MRI
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Universidad de Almería | Almería | Spain |
More Universidad de Almeria trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07386665 on ClinicalTrials.gov ↗ ← All trials in Spain